Kazia Therapeutics Limited Gains 31.71%
Wed, Dec 03, 2025 at 07:41 PM
Kazia Therapeutics Limited (KZIA:NASDAQ) shot up at $13.25, representing a gain of 31.7%. On Wed, Dec 03, 2025, KZIA:NASDAQ hit a New 2-Week High of $13.25. The stock appeared on our News Catalysts scanner on Tue, Dec 02, 2025 at 11:45 AM in the 'PRIVATE PLACEMENT' category. From Wed, Nov 19, 2025, the stock recorded 66.67% Up Days and 60.00% Green Days
The stock spiked on Tue, Nov 25, 2025 at $14.42 with a volume of 1M+.
About Kazia Therapeutics Limited (KZIA:NASDAQ)
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 1780%
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 371.07%
- Nauticus Robotics, Inc. (KITT:NASDAQ), 115.89%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 75.11%
- iRobot Corporation (IRBT:NASDAQ), 73.85%
- Micropolis Holding Company (MCRP:NYSEMKT), 51.28%
- Q/C Technologies Inc Com Par $0.001 (QCLS:NASDAQ), 38.17%
- Kaixin Holdings (KXIN:NASDAQ), 33.87%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 31.71%
- MapLight Therapeutics Inc. (MPLT:NASDAQ), 31.26%